Athira Pharma Inc.
0.53
-0.00 (-0.21%)
At close: Jan 14, 2025, 3:59 PM
0.53
-0.09%
After-hours Jan 14, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.79 -1.37 -8.85 -59.71 -118.7 -20.77
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 0.71 0.51 1.50 4.06 -28.3 -7.11
P/FCF Ratio -0.91 -1.62 -10.77 -42.09 -150.31 -23.61
P/OCF Ratio -0.92 -1.65 -11.16 -46.14 -150.31 -23.61
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.01 0.01 0.00 -0.08 -0.05
Quick Ratio 5.37 9.74 28.32 43.96 1.70 8.56
Current Ratio 5.37 9.68 28.07 43.66 1.70 8.56
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -4.28 -21.34K -54.48 -15.75 -556.56
Return on Equity (ROE) -0.9 -0.37 -0.17 -0.07 0.24 0.34
Return on Assets (ROA) -0.73 -0.34 -0.16 -0.07 -2.15 -1.03
Return on Capital (ROIC) -0.95 -0.44 -0.2 -0.07 -5.95 -1.15
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a